Business

GST Reforms Transform India’s Pharmaceutical & Healthcare Sector

India’s recent Goods and Services Tax (GST) reforms are reshaping the pharmaceutical and healthcare industry, enhancing patient affordability, streamlining compliance, and boosting India’s global standing as the ‘Pharmacy of the World’ and an innovation hub.

GST Cuts Enhance Patient Affordability

The GST Council has reduced rates on all medicines (except exempted drugs) from 12% to 5%, directly lowering out-of-pocket expenses for patients. Medicines remain a non-discretionary household expense, and the tax reduction significantly eases the financial burden on families.

Additionally, the Council exempted 36 essential medicines, including life-saving drugs for cancer, rare diseases, and critical treatments, from GST. These measures particularly benefit patients requiring long-term or specialised therapies.

Over the past year, coordinated fiscal reforms—including a reduction in Basic Customs Duty (BCD) on cancer formulations and the September 2025 GST rationalisation- have cut prices of key medicines, yielding up to 14.2% savings for consumers.

The reforms reflect strong collaboration between industry, regulators such as the National Pharmaceutical Pricing Authority (NPPA), and trade bodies.

Regular dialogue ensured a balance between industry sustainability and patient affordability, promoting transparent, predictable, and patient-focused policies.

Lower GST rates will reduce medicine prices for consumers, boosting goodwill for the industry. Companies must now ensure the benefits are passed on transparently across the supply chain.

However, the transition presents challenges. Businesses must adjust invoicing, pricing, and distribution systems while navigating complexities such as zero-GST input tax credit calculations. Coordinated efforts are essential to realign MRPs and ensure smooth implementation at retail levels.

These reforms go beyond taxation, laying the foundation for a more efficient, inclusive, and transparent healthcare system. By easing financial strain on patients, the government encourages higher consumption of quality healthcare services, driving investment and innovation in the sector.

Industry stakeholders, including OPPI and member companies, have pledged to deliver GST benefits efficiently and transparently to patients, ensuring affordability and access remain central to India’s healthcare vision.

Also Read: India’s Petroleum Product Exports Rise To One-Year High In September

Purnima Mishra

Recent Posts

Union Home Minister To Open India Maritime Week 2025; Focusing On Trade & Sustainability

Union Home Minister Amit Shah will officially inaugurate India Maritime Week 2025 on October 27…

37 mins ago

PM Modi Pays Tribute To Satish Shah; Hails Him As ‘Legend Of Indian Entertainment’

PM Modi mourned the demise of Satish Shah, highlighting the actor’s iconic performances and humour…

2 hours ago

Bharat Express CMD Upendrra Rai’s Elder Brother Rajesh Rai Passes Away; Final Rites On 27 October

Rajesh Rai, elder brother of Bharat Express CMD Upendrra Rai, passed away in Delhi on…

3 hours ago

Railway Fact Check Denies Lalu’s Charge Of Fewer Trains For Bihar During Chhath Festival

RJD chief Lalu Prasad Yadav accused the Central government of misleading the public by promising…

4 hours ago

Virat Kohli Becomes Second-Highest Run-Getter In ODIs

Indian cricket star Virat Kohli surpassed Kumar Sangakkara to become the second-highest run-scorer in One-Day…

5 hours ago

Amit Shah Accuses Lalu Regime Of Lawlessness & Industrial Decline At Bihar Rally

Union Home Minister Amit Shah launched a sharp attack on RJD chief Lalu Prasad Yadav…

6 hours ago